Maithili Kamat Email

Senior Systems and Test Engineer . NuPulseCV

Current Roles

Employees:
41
Revenue:
$10.3M
About
The iVAS medical device (ambulatory counterpulsation) by NuPulseCV is being evaluated through a clinical trial as an option for patients who have advanced heart failure and who are no longer benefiting from guideline directed medical therapies. The iVAS is a less invasive option that may help address heart failure symptoms (NYHA III and IV), which may allow a heart failure patient to return to daily activities. Contact us at [email protected] or 1-800-216-1778.
NuPulseCV Address
5734 Trinity Road
Raleigh, NC
United States
NuPulseCV Email